Navigation Links
Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
Date:1/28/2008

PHOENIX, Jan. 28 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," announced today that financial results for the third fiscal quarter ended December 31, 2007 will be released after the market closes on Wednesday January 30, 2008. An earnings conference call will be held the following morning on Thursday, January 31, 2008 at 11:00 AM ET.

To access the teleconference, please call (877) 863-5191 (domestic) or (706) 643-6826 (international), access number 32145727. To listen to the teleconference via the Internet, go to http://www.matrixxinc.com and click on the third quarter fiscal 2008 teleconference icon.

A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 32145727 for 3 days following the call, and the web cast will be archived on the company's website, http://www.matrixxinc.com, for 30 days.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journa
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
2. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. Harm of Abstinence-Only Programs in U.S. and Abroad Subject of Panel Discussion at Two Maine College Campuses
5. New Blog Provides Forum for Discussions on Supplement Safety
6. Early Detection Push from New Alzheimers Disease Discussion Group Points to Advances by Startup Companies, Including Louisville-Based Neuronetrix, Inc.
7. Finding the right words: Provider-patient discussions can help domestic violence victims speak up
8. Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference
9. Air Products in Advanced Discussions With Wacker Over Polymers Business
10. Peak International Sets Time for Discussion of Second Quarter Fiscal 2008 Financial Results
11. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...RNewswire-FirstCall/ -- ViroPharma Incorporated,(...submitted a supplemental,Biologics License Applic...ion,(FDA) for Cinryze(TM) C1 Inhibitor (human) as...oedema (HAE). , The sBLA is based on a re-a...hase 3 acute treatment study of Cinryze and interi...
(Date:12/1/2008)...PRNewswire/ -- Media entrepreneur, television and,... and philanthropist John,Bendheim will be honored...annual "Road To A Cure" Gala, December 2, 2008, at...ell, Chairman of the Board of Governors, co-chairs...an and Fran Solomon. The "Road To,A Cure" Gala i...
(Date:12/1/2008)..., personality illnesses common, study shows , ...atric disorders are common among young adults in t...port shows. , To reach this finding, U.S. resea...nts, aged 19 to 25, who took part in the National ...ions. , The study found that 45.8 percent of th...
(Date:12/1/2008)...with the agency,s goals, commitment and resources ... Responding to criticism that it has done a poor j... Food and Drug Administration released a report Mo..., Among the most important changes in 2008 was t...ps with state and local health departments to prot...
Breaking Medicine News(10 mins):Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5Health News:Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual 'Road To A Cure' Gala 2Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4
...s Aureus, or MRSA, a type of bacteria resistant to...ic health; it spreads through// direct contact and...eople. This infection is thought to be dormant ...o apparent signs of sickness, which makes it all t...
...ed in two more districts in Cambodia's eastern pro... 3000 ducks have died in the last week.// "We hav...t has not infected the people yet," Kao Phal, the ...the agriculture ministry, told AFP on Friday. "Th...
...e to alleged negligence by doctors, attacked the m...pital Sunday// in the coastal city of Visakhapatna...cer were injured in the attack while six doctors a...ospital for safety. Tension prevailed at the hosp...
... the Mahim beach to drink sweet seawater for the s...d people against drinking// the polluted water. S...weet due to the natural phenomenon of dilution. "...bserved all along the western coast of India durin...
Other Medicine News:Health News:Maharashtra warns against Mahim's 'miracle' water 2
(Date:12/1/2008)... TargeGen has announced that an or...lti-center, US-based clinical,trial of TG101348 i...eduled at,the 2008 American Society of Hematology...tion are as follows:, Title: A ..., JAK2-Selective Inhibitor,...
(Date:12/1/2008)...pophosphatasia Treated With ENB-0040 at Children,s... , MONTREAL, Dec. 1 Enobia Pha...on developing novel therapeutics for serious bone ...atient in its clinical program for hypophosphatasi...ement Therapy (ERT) with ENB-0040 for the treatmen...
(Date:12/1/2008)... Pa., Dec. 1 Genaera Co...osing of subjects has begun in study MSI-1436C-102... study of trodusquemine (MSI-1436) in overweight a...rapeutic for the treatment of type 2 diabetes and ...regulate insulin and leptin pathways through the h...
(Date:12/1/2008)...PRNewswire-FirstCall/ -- GeoVax Labs, Inc.,(OTC B...gy company developing,human vaccines for diseases...d,other infectious agents, announced today that t...ll take place in twelve sites across North and Sou...ration with The National Institutes of,Health (NI...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3More Elderly Americans Living With Heart Failure 12663 1More Elderly Americans Living With Heart Failure 12663 2New Legal Momentum Publication Exposes How Abstinence Only Programs Harm Women and Girls 12658 1New Legal Momentum Publication Exposes How Abstinence Only Programs Harm Women and Girls 12658 2New Legal Momentum Publication Exposes How Abstinence Only Programs Harm Women and Girls 12658 3Silica smart bombs deliver knock out to bacteria 12653 1Silica smart bombs deliver knock out to bacteria 12653 2Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1
....--(BUSINESS WIRE)--Jul 11, 2007 - BioSante,Pharma...sitive,results demonstrating that its calcium phos...ioVant(TM), may serve as an,effective vaccine adju... against H5N1 avian flu, widely known as bird flu....agglutination,inhibition assay (HAI), which showed...
...ed in Oral Presentation at International Symposium...007 /PRNewswire-FirstCall/ -- Baxter,Healthcare Co...ings,from the ADAPT (Analysis of Data from ADVATE(...ing a statistically significant,relationship betwe...od levels below one international unit per decilit...
Other Medicine Technology:BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 2BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 3BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 4Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 2Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 3Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 4Clinical Data Suggest Decreased Bleeding Risk in People With Severe,Hemophilia A While Maintaining Factor VIII Levels Above One Percent 5
Premium Tennis Elbow Support is 2" wide with loop-lock contact closure and is foam-lined for comfort.
... The new "Innovation Joint Technology" elbow brace...s to help re-establish pain free range of motion. ...red to provide the clinician and patient with adju...nt use includes Wrist and Forearm Fractures, Post ...
... The new "Innovation Joint Technology" elbow brace...s to help re-establish pain free range of motion. ...djustable flexion and extension dynamic force. Ran...de physicians and therapists versatility with thei...
Designed to provide comfortable immobilization of the elbow
Medicine Products: